| Literature DB >> 29029606 |
Christine M Goertz1,2, Stacie A Salsbury3, Cynthia R Long3, Robert D Vining3, Andrew A Andresen4, Maria A Hondras5, Kevin J Lyons6, Lisa Z Killinger7, Fredric D Wolinsky8, Robert B Wallace9.
Abstract
BACKGROUND: Low back pain is a debilitating condition for older adults, who may seek healthcare from multiple providers. Few studies have evaluated impacts of different healthcare delivery models on back pain outcomes in this population. The purpose of this study was to compare clinical outcomes of older adults receiving back pain treatment under 3 professional practice models that included primary medical care with or without chiropractic care.Entities:
Keywords: Care coordination; Integrative medicine; Low back pain; Older adults; Pain management; Randomized controlled trial
Mesh:
Year: 2017 PMID: 29029606 PMCID: PMC5640949 DOI: 10.1186/s12877-017-0624-z
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Fig. 1CONSORT flow chart
Participant Baseline Characteristics by Treatment Group
| Characteristic | Shared Care, | Dual Care, | Medical Care, |
|---|---|---|---|
| Age, years, mean ± SD | 73.2 ± 6.2 | 72.3 ± 6.0 | 72.7 ± 6.4 |
| Gender, male, n (%) | 28 (64) | 28 (64) | 24 (56) |
| Race, white, n (%) | 40 (91) | 43 (98) | 40 (93) |
| Employment, current, n (%) | 4 (9) | 11 (25) | 11 (26) |
| Body mass index, mean ± SD | 31.9 ± 5.7 | 31.8 ± 7.3 | 31.7 ± 7.0 |
| Timed Up & Go, seconds, mean ± SDa | 12.3 ± 5.3 | 11.1 ± 2.6 | 11.6 ± 3.8 |
| RAND-36, mean ± SD (range 0–100)b | |||
| Physical function | 50.0 ± 26.9 | 57.8 ± 23.6 | 65.0 ± 23.3 |
| Emotional well-being | 78.5 ± 13.1 | 80.4 ± 14.0 | 77.8 ± 13.3 |
| Patient Health Questionnaire, n (%) | |||
| None-to-minimal depression | 27 (62) | 32 (73) | 31 (72) |
| Mild-to-moderate depression | 15 (34) | 11 (25) | 12 (28) |
| Generalized Anxiety Disorder, n (%) | |||
| None-to-minimal anxiety | 37 (84) | 38 (86) | 34 (79) |
| Mild-to-moderate anxiety | 7 (16) | 6 (13) | 9 (21) |
| LBP onset, ≥1 year, n (%) | 40 (91) | 37 (84) | 33 (77) |
| LBP days per week, median ± IQR | 7.0 ± 6.0 | 7.0 ± 5.0 | 7.0 ± 7.0 |
| LBP medication use, past week, n (%) | |||
| 0 days of medication use | 15 (34) | 16 (36) | 16 (37) |
| 1–6 days of medication use | 14 (32) | 17 (38) | 17 (40) |
| 7 days of medication use | 15 (34) | 11 (25) | 10 (23) |
| Types of LBP medication, n (%) | |||
| Opioids or narcotics | 4 (9) | 4 (9) | 5 (12) |
| Over-the-counter medicine | 23 (52) | 16 (36) | 17 (40) |
| Non-steroidal anti-inflammatories | 17 (39) | 24 (55) | 19 (44) |
| Sedatives or muscle relaxants | 7 (16) | 5 (11) | 5 (12) |
| Days cut down on activity in past 4 weeks due to LBP, median ± IQR | 2 (0–10.0) | 4 (0–8.5) | 5 (0–20.0) |
| Bothersomeness mean ± SD (range 1–5)a | 3.5 ± 0.8 | 3.4 ± 0.8 | 3.3 ± 0.8 |
| Fear avoidance beliefs, work or daily activity, mean ± SD (range 0–42)a | 14.7 ± 8.7 | 13.0 ± 10.0 | 10.4 ± 8.4 |
| Fear avoidance beliefs, physical activity, mean ± SD (range 0–24)a | 12.8 ± 6.0 | 11.8 ± 6.2 | 12.0 ± 5.0 |
| Numerical rating scale, average LBP in past week, mean ± SD (range 0–10)a | 5.3 ± 1.9 | 6.0 ± 1.9 | 6.1 ± 1.9 |
| Numerical rating scale, worst LBP in past week, mean ± SD (range 0–10)a | 7.3 ± 1.5 | 7.4 ± 1.8 | 7.5 ± 1.5 |
| Roland Morris Disability Questionnaire, mean ± SD (range 0–24)a | 9.0 ± 5.2 | 7.1 ± 4.4 | 6.3 ± 4.9 |
aLower score indicates better functioning
bHigher score indicates better functioning
IQR Interquartile range, LBP Low back pain, SD standard deviation
Adjusted mean changes form baseline to week 12 and differences between group-changes with confidence intervals (CI)a
| Variable | Treatment Group | Mean Change (95% CI) | Mean Difference (95% CI) | ||
|---|---|---|---|---|---|
| Shared vs. Dual | Shared vs. Medical | Dual vs. Medical | |||
| Roland Morris Disability | Shared | 2.8 (1.6 to 4.0) | 0.3 (−1.5 to 2.0) | 1.3 (−0.5 to 3.0) | 1.0 (−0.8 to 2.8) |
| Dual | 2.5 (1.3 to 3.7) | ||||
| Medical | 1.5 (0.2 to 2.8) | ||||
| NRS-Average | Shared | 1.8 (1.0 to 2.6) | −1.2 (−2.3 to −0.1) | −0.5 (−1.7 to 0.6) | 0.7 (−0.4 to 1.8) |
| Dual | 3.0 (2.3 to 3.8) | ||||
| Medical | 2.3 (1.5 to 3.2) | ||||
| NRS-Worst | Shared | 2.1 (1.3 to 2.9) | −0.8 (−1.8 to 0.3) | −0.2 (−1.3 to 0.9) | 0.6 (−0.5 to 1.7) |
| Dual | 2.9 (2.1 to 3.6) | ||||
| Medical | 2.3 (1.5 to 3.1) | ||||
| LBP Bothersomeness | Shared | 0.8 (0.4 to 1.1) | −0.2 (−0.6 to 0.3) | 0.2 (−0.3 to 0.6) | 0.3 (−0.1 to 0.8) |
| Dual | 0.9 (0.6 to 1.2) | ||||
| Medical | 0.6 (0.3 to 0.9) | ||||
| FABQ-Work or Daily Activity | Shared | 3.5 (0.7 to 6.3) | 0.6 (−3.4 to 4.5) | 2.6 (−1.5 to 6.7) | 2.1 (−2.0 to 6.1) |
| Dual | 2.9 (0.2 to 5.7) | ||||
| Medical | 0.9 (−2.1 to 3.9) | ||||
| FABQ-Physical Activity | Shared | 1.6 (−0.3 to 3.5) | −0.7 (−3.4 to 1.9) | 0.6 (−2.2 to 3.4) | 1.4 (−1.4 to 4.2) |
| Dual | 2.3 (0.4 to 4.2) | ||||
| Medical | 0.9 (−1.1 to 3.0) | ||||
| Timed Up & Go | Shared | 0.9 (0.0 to 1.9) | 0.4 (−1.0 to 1.7) | 1.3 (−0.1 to 2.7) | 0.9 (−0.5 to 2.3) |
| Dual | 0.5 (−0.4 to 1.5) | ||||
| Medical | −0.4 (−1.4 to 0.7) | ||||
aValues estimated from a mixed-effects model using all observed data and an unstructured covariance
NRS 0 to 10 numerical rating scale, LBP Low back pain, FABQ Fear Avoidance Beliefs Questionnaire
Fig. 2Percent of participants reporting levels of a. Global perceived improvement of low back pain, b. Overall health, and c. Quality of life
Fig. 3Percent of participants reporting levels of satisfaction for the information received regarding the cause of low back pain (LBP) (a), prognosis of LBP (b) and activities that hasten recovery (c), concern by MDs and DCs during treatments (d), the quality of the treatment recommendations(e) and the overall care for LBP (f)
Reported Serious Adverse Events and Medication Side Effects
| Treatment Group | Event Description | Grading |
|---|---|---|
| Shared Care | Hospitalization for flare up of existing chronic obstructive pulmonary disease | Serious, Unrelated to Study |
| Dual Care | Hospitalization for amaurosis fugax and carotid artery blockage diagnosed by outside provider during study enrollment process | Serious, Unrelated to Study |
| Dual Care | Hospitalization for pneumonia and atrial fibrillation | Serious, Unrelated to Study |
| Dual Care | Hospitalization for chest pain diagnosed as reflux esophagitis by outside provider | Serious, Unrelated to Study |
| Medical Care | Hospitalization for accidental fall with pneumothorax | Serious, Unrelated to Study |
| Unallocated | Hospitalization for renal lithiasis with sepsis during study enrollment process | Serious, Unrelated to Study |
| Shared Care | Hospitalization for chest pain with cardiac catheterization | Serious, Unlikely Related to Study |
| Dual Care | Hospitalization for ischemic colitis | Serious, Unlikely Related to Study |
| Shared Care | Medication side effect of vomiting after taking a muscle relaxant that resolved with discontinuation | Moderate, Definitely Related to Study |
| Shared Care | Medication side effect of dermal burning sensations from a nicotine patch that resolved with discontinuation | Mild, Definitely Related to Study |
| Medical Care | Medication side effect of jerking sensations in an arm after gabapentin use that resolved with a dose change | Mild, Possibly Related to Study |